Divergent ERα Co-factor Landscapes in Gynecological Cancers: Implications for Disease Progression and Therapy
{{output}}
Estrogen receptor alpha (ERα) is an established biomarker for breast tumors, the loss of which is associated with poor cancer progression. Over 70% of breast cancers express ERα and targeting this protein has helped stem the progress of breast cancer. Theref... ...
